← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FOUGERA PHARMS · Approved 2006-07-25

Drug application

FDA Application #
ANDA065320
Application type
Abbreviated New Drug Application (Generic)
Brand name
ERYTHROMYCIN
Generic name
Erythromycin
Active ingredients
ERYTHROMYCIN
Dosage form
SWAB
Route
TOPICAL
Marketing status
Discontinued
Sponsor
FOUGERA PHARMS
First approval
2006-07-25

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown